FMR CORP 13D/13G Filings for Leap Therapeutics, Inc. (LPTX)

FMR CORP 13D and 13G filings for Leap Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-08
10:27 am
Sale
2021-02-05 13G Leap Therapeutics, Inc.
LPTX
FMR CORP 60,600
1.005%
-66,080decrease
(-52.16%)
Filing